MedTrace Logo

Predictor of Advanced Subclinical Atherosclerosis

NCT00245284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2006-06-06

No results posted yet for this study

Summary

Evaluation of skin cholesterol for cardiovascular risk assessment in asymptomatic individuals at low, intermediate, or high risk based on Framingham Global Risk estimates. Carotid intima-media thickness (IMT), a surrogate marker for atherosclerotic burden, that independently predicts the occurrence of heart attack and stroke, will be the "gold standard" comparator.

Hypothesis: Skin cholesterol, as measured by two non-invasive tests, correlates with CAD, as measured by CIMT in this population.

Conditions

Sponsors & Collaborators

  • PreMD

    lead INDUSTRY

Principal Investigators

  • James Stein, MD · University of Wisconsin, Madison

  • Michael Davidson, MD · Radiant Research - Chicago

  • Ouyang Pamela, MD · Johns Hopkins University

  • Decara Jeanne, MD · University of Chicago

  • Mohler Emile, MD · University of Pennsylvania

  • Hirsch Alan, MD · University of Minnesota

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00245284 on ClinicalTrials.gov